Aarvik Therapeutics

0 followers


Aarvik Therapeutics is pursuing exciting, novel molecules with an improved therapeutic index for several oncology targets by combining a novel modular antibody platform with multiple target mechanisms.

Industries

Employees

11-50

Links

Org chart

Jagath Reddy Junutula
Co-founder, President & CEO

Jagath Reddy Junutula

Collapse
Reva Raghupathi
Chief Business Officer
Vasu Jamma
VP, Chemistry
Sunil Bhakta
VP, Research Operations
Vidya Jonnalagadda
Executive Director, Data Sciences
Viswanatham Katta
Executive Director, Process Development
Heather Maecker
Business Advisor
Jiang Liu
Senior Director, Molecular Oncology
Ram Reddy
Board Member & Principal Investor
Stuart Lutzker
Aarkus Therapeutics Scientific Advisory Board
Greg Cosma
Scientific Advisory Board